Selective lysosomal uptake and accumulation of the beta-adrenergic antagonist propranolol in cultured and isolated cell systems

doi:10.1016/0006-2952(86)90283-2

Biochemical Pharmacology

Volume 35, Issue 8, 15 April 1986, Pages 1365-1372

https://doi.org/10.1016/0006-2952(86)90283-2 Get rights and content

Abstract

The beta adrenoreceptor antagonist propranolol is rapidly taken up and accumulated in various cultured cell lines. When incubated in the presence of low concentrations of propranolol (1(T⁻⁹M), Hela (non-differentiated epithelia), BC₃H₁ (smooth muscle) and MDCK (differentiated kidney epithelia) cell cultures take up (t_1/2 = 4–10 min) and accumulate the drug such that the intracellular concentration is over 1000 times that in the incubation medium. The release of propranolol from the cells was slower ( $t_{12} = 22 min$ ) than the rate of uptake but the dissociation was stimulated by the addition of 1 μM propranolol to the external medium ( $t_{12}$ = 9 min). Uptake, which is non-stereoselective, is dependent on pH and is inhibited by the lysosomotropic agents, NH₄Cl, methylamine and chloroquine. At higher concentrations (>10⁶M), uptake is accompanied by a visual swelling of intracellular acidic vesicles staining with acridine orange. These results suggest that propranolol, a basic amphiphilic amine. is accumulated within the lysosomes of these cells. Uptake was confined to these cultured cell systems with no chloroquine-sensitive propranolol uptake, being found in isolated rabbit ventricular myocytes, red blood cells or blood platelets.

Although alprenolol and cyanopindolol competed with propranolol for uptake, isoprenaline, adrenaline, noradrenaline, phenylephrine, atenolol, practolol and salbutamol were not effective inhibitors.

The possible consequences of this uptake and accumulation of propranolol by certain tissues is discussed in relation to the known actions of the drug, particularly during or after abrupt withdrawal from chronic applications.

References (50)

G. Glaubiger et al.
Biochem. biophys. Res. Commun.
(1977)
G. Cramb et al.
Biochem. Pharmac.
(1984)
B.H. Dulis et al.
Biochim. biophys. Acta
(1981)
H. Komai et al.
Biochem. Pharmac.
(1979)
Y-H. Wei et al.
Biochem. Pharmac.
(1985)
A.S. Pappu et al.
Biochem. Pharmac.
(1985)
M. Shigekawa et al.
Biochim. biophys. Acta.
(1979)
I. Pastan et al.
TIBS
(1983)
A. Helenius et al.
TIBS
(1983)
J. Patrick et al.
J. biol. Chem.
(1977)

J.F. Aiton et al.

Biochim. biophys. Acta

(1981)

G. Cramb et al.

Biochem. Pharmac.

(1983)

J.F. Aiton et al.

Biochem. Pharmac.

(1985)

Y. Matsuzawa et al.

J. Lipid Res.

(1980)

Y. Stein et al.

Biochim. biophys. Acta

(1977)

K.Y. Hostetler et al.

Biochem. Pharmac

(1981)

H.F. Mizgala et al.

Can. J. Med.

(1976)

R.R. Miller et al.

N. Engl. J. Med.

(1975)

E.L. Alderman et al.

Ann. Int. Med.

(1974)

H. Boudoulas et al.

Ann. Int. Med.

(1977)

S. Nattel et al.

Circulation

(1979)

R.D. Aarons et al.

J. Pharmac. exp. Ther.

(1982)

B.A. Hemsworth et al.

Br. J. Pharmac.

(1981)

D.M. Geddes et al.

Thorax

(1979)

S.B.deC. Baker et al.

Cited by (37)

Combination of spontaneous regional brain activity and HTR1A/1B DNA methylation to predict early responses to antidepressant treatments in MDD
2022, Journal of Affective Disorders
Citation Excerpt :
Several studies have shown that methylation of certain sites within serotonin pathway genes such as the serotonin transporter gene (SLC6A4), tryptophan hydroxylase 2 gene (TPH2), and serotonin receptor gene (HTR1A, HTR1B) was connected to the outcomes of the antidepressant treatment (Gasso et al., 2017; Schiele et al., 2021; Shen et al., 2020; Wang et al., 2018). Nowadays, most clinical antidepressant drugs are based on the “monoamine hypothesis”, which may regulate the levels of monoamine transmitters (e.g., serotonin, dopamine, and norepinephrine) between synapses to achieve the antidepressant effect (Cramb, 1986). The 5-HT1A and 5-HT1B receptors, present both pre- and post-synaptically, are broadly distributed in the central nervous system, and their function can influence the activity of serotonergic neurons (Mekli et al., 2011).
Antidepressant medications are suggested as the first-line treatment in patients with major depressive disorder (MDD). However, the drug therapy outcomes vary from person to person. The functional activity of the brain and DNA methylation levels correlate with the antidepressant efficacy. To predict the early antidepressant responses in MDD and establish the prediction framework, we aimed to apply multidimensional data based on the resting-state activity of the brain and HTR1A/1B methylation.
The values of Amplitude of Low-Frequency Fluctuations (ALFF) and regional homogeneity (ReHo) were measured as variables in 116 brain regions along with 181 CpG sites in the promoter region of HTR1A/1B and 11 clinical characteristics. After performing the feature reduction step using the least absolute shrinkage and selection operator (LASSO) method, the selected variables were put into Support Vector Machines (SVM), Random Forest (RF), Naïve Bayes (NB), and logistic regression (LR), consecutively, to construct the prediction models. The models’ performance was evaluated by the Leave-One-Out Cross-Validation.
The LR model composed of the selected multidimensional features reached a maximum performance of 78.57% accuracy and 0.8340 area under the ROC curve (AUC). The prediction accuracies based on multidimensional datasets were found to be higher than those obtained from the data based only on fMRI or methylation.
A relatively small sample size potentially restricted the usage of our prediction framework in clinical applications.
Our study revealed that combining the data of brain imaging and DNA methylation could provide a complementary effect in predicting early-stage antidepressant outcomes.
Cytotoxicity of binary mixtures of human pharmaceuticals in a fish cell line: Approaches for non-monotonic concentration-response relationships
2014, Chemosphere
Citation Excerpt :
To investigate whether differences in lysosomal number or structure were apparent, pharmaceutical-exposed cells were examined microscopically after incubation in the presence of neutral red (Fig. 1). In the case of PPN, the appearance of large, swollen lysosomes probably indicates direct lysosomal uptake and accumulation of PPN, which has been reported previously for this compound (Cramb, 1986). A degree of lysosomal swelling was also visible in cells treated with FL, although the degree of uptake appeared to be marked less than that observed for PPN.
Predicting the effects of mixtures of environmental micropollutants is a priority research area. In this study, the cytotoxicity of ten pharmaceuticals to the rainbow trout cell line RTG-2 was determined using the neutral red uptake assay. Fluoxetine (FL), propranolol (PPN), and diclofenac (DCF) were selected for further study as binary mixtures. Biphasic concentration–response relationships were observed in cells exposed to FL and PPN. In the case of PPN, microscopic examination revealed lysosomal swelling indicative of direct uptake and accumulation of the compound. Three equations describing non-monotonic concentration–response relationships were evaluated and one was found to consistently provide more accurate estimates of the median and 10% effect concentrations compared with a sigmoidal concentration–response model. Predictive modeling of the effects of binary mixtures of FL, PPN, and DCF was undertaken using an implementation of the concentration addition (CA) conceptual model incorporating non-monotonic concentration–response relationships. The cytotoxicity of the all three binary combinations could be adequately predicted using CA, suggesting that the toxic mode of action in RTG-2 cells is unrelated to the therapeutic mode of action of these compounds. The approach presented here is widely applicable to the study of mixture toxicity in cases where non-monotonic concentration–response relationships are observed.
A live-cell fluorescence microplate assay suitable for monitoring vacuolation arising from drug or toxic agent treatment
2010, Journal of Biomolecular Screening
Citation Excerpt :
Two of these agents, propranolol and GF-109203X, have previously been reported to induce phospholipidosis in cells. Propranolol is a well-known and extensively investigated cationic amphiphilic drug that induces phospholipidosis.17,19 High micromolar concentrations of the drug are rapidly taken up and accumulated by a wide range of cultured cells, with a steady state being reached after 40- to 60-min administration and half-maximum uptake within 4 to 10 min.
Lysosomes are membrane-bound subcellular organelles involved in the degradation of macromolecules and pathogens in diverse processes, including endocytosis, phagocytosis, and autophagy. A red fluorescent probe was developed that is selectively sequestered in acidic organelles. U20S cells pretreated with 64 µM chloroquine for as little as 5 h show a dramatic increase in lysosome-like vesicle number and volume. The probe can be employed for highlighting lysosome-like organelles under conditions wherein cells produce vacuoles that contain most of the degradative enzymes of the lysosome but are not as acidic as the parent organelle. Using a conventional fluorescence microplate reader, the half-maximal effective concentration (EC₅₀) of chloroquine was estimated. The high Z′ score obtained using the assay demonstrated excellent signal-to-noise ratios. The fluorescence microplate assay was successfully employed to screen a small-molecule compound library for agents that increase lysosomal volume and number. One potential application of the new assay is in the toxicology portion of preclinical drug safety assessment (ADME-Tox) workflows, using in vitro cell culture models to aid in the drug development process.
Contribution of lysosomes to concentrative uptake of DX-9065a into rat liver
2006, Journal of Pharmaceutical Sciences
Citation Excerpt :
After a single intravenous administration of [14C]-DX-9065a to rats, the radioactivity in the liver continuously increased up to 6 h and showed a Kp value of 90.5, representing concentrative uptake against the radioactivity concentration gradient between liver and plasma. To account for the concentrative uptake phenomena of cationic organic compounds in certain tissues, some mechanisms have been proposed in the literature, and they can be categorized into two types: (A) binding to intracellular components of phosphatidylserine,23,24 lysosomes,22,25–29 and mitochondria;21 and (B) uptake by a carrier protein17,30 or a receptor-mediated endocytosis system.18,31 In many cases, however, the contribution of each mechanism was evaluated solely, and it is, therefore, still unclear which mechanism predominantly accounts for the concentrative distribution profile of the corresponding drug.
This study evaluates the distribution profile in tissues and concentrative uptake mechanism for a cationic compound of DX-9065a in rats. After a single intravenous dosing of [¹⁴C]-DX-9065a to male rats, higher levels of radioactivity were observed in kidney and liver. Moreover, the radioactivity in the liver continuously increased up to 6 h after intravenous dosing and a concentrative uptake of the drug against the radioactivity gradient between plasma and liver, showing K_p value of 90.7. In contrast, carrier-mediated systems did not play a significant role in the uptake of DX-9065a by hepatocytes. A subcellular distribution study was conducted by means of Percoll density gradient centrifugation and revealed a high affinity of the compound with the lysosomes. It was concluded that DX-9065a permeated into hepatocyte across the membrane primarily by passive diffusion, and the consequent process of lysosomal trapping played a major role in the concentrative uptake of the drug into the liver.
α-Tocopherol influences the lipid membrane affinity of desipramine in a pH-dependent manner
2004, European Journal of Pharmaceutical Sciences
Phopholipidosis is a lipid storage disorder caused by cationic amphiphilic drugs (CADs) characterized by the lysosomal accumulation of phospholipids and drug. α-Tocopherol (α-Toc) has a reversible effect on phospholipidosis in rats and cell culture. We studied the influence of α-Toc on the partitioning of the CAD desipramine in a liposome/buffer system using equilibrium dialysis with the following lipid compositions: egg phosphatidylcholine (PhC) or wheat germ phosphatidylinositol (PhI) or a combination of PhC, PhI and cholesterol, containing between 1.5 and 20% (mol per mol total lipids) of α-Toc, α-tocopherol acetate (α-TocAc), 2,2,5,7,8-pentamethyl-6-chromanol (PMC) or cholesterol. α-Toc (1.5%) enhanced the partition coefficient of neutral desipramine by up to 1.1 log units while it had no influence on the partitioning of the ionized compound. In the PhC liposome system, at pH 7.4 log D increased with increasing α-Toc concentrations but was unchanged at pH 4.5. Similar effects were found with PMC while α-TocAc or cholesterol, between 1.5 and 20%, had no influence on the partitioning of desipramine. From these results we postulate that in vivo, α-Toc could mediate a redistribution of CADs from lysosomal membranes (pH ∼4.5) to membranes and lipoproteins at physiological pH.
Antioxidant and lysosomotropic properties of acridine-propranolol: Protection against oxidative endothelial cell injury
2002, Journal of Molecular and Cellular Cardiology
The antioxidant and lysosomotropic properties of a fluorescent analogue of propranolol, 9-amino-acridine-propranolol (9-AAP) were compared to those of propranolol. Using isolated microsomal membranes exposed to a superoxide and hydroxyl radical generating system, 9-AAP was found to be at least 10-fold more potent than propranolol (and about 50% as potent as vitamin E) in inhibiting lipid peroxidation. In cultured endothelial cells, 9-AAP afforded moderate protective effect against acute loss of glutathione but potent cytoprotective activity against free radical-mediated loss of viability/survival. Intracellular localization of 9-AAP was examined by fluorescent microscopy and compared with two known fluorescent lysosomal markers: acridine orange and Lysosensor. All three agents appeared to localize to similar peri-nuclear vesicles, presumably lysosomes or pre-lysosomes. Lysosensor fluorescence was not observable in the presence of 9-AAP, foreclosing the possibility of a direct dual labeling experiment. We employed the pH sensitivity of acridine orange to determine if it labels the same vesicles as 9-AAP. When the endothelial cells were preloaded with acridine orange, washed and resuspended in buffer containing 9-AAP, the dark orange-labeled vesicles observed with acridine orange alone became increasingly lighter with time. Since the fluorescence of acridine orange is altered by pH change, this spectral shift in fluorescence emission is consistent with the indication that added propranolol (or the analog) leads to lysosomal alkalization. In conclusion, 9-AAP is both a strong antioxidant and a lysosomotropic agent that is remarkably insensitive to photobleaching . These properties may contribute to the enhanced endothelial cytoprotective effects against free radical-induced injury.

View all citing articles on Scopus

View full text

Research paperSelective lysosomal uptake and accumulation of the beta-adrenergic antagonist propranolol in cultured and isolated cell systems

Abstract

Biochem. biophys. Res. Commun.

Biochem. Pharmac.

Biochim. biophys. Acta

Biochem. Pharmac.

Biochem. Pharmac.

Biochem. Pharmac.

Biochim. biophys. Acta.

TIBS

TIBS

J. biol. Chem.

Biochim. biophys. Acta

Biochem. Pharmac.

Biochem. Pharmac.

J. Lipid Res.

Biochim. biophys. Acta

Biochem. Pharmac

Can. J. Med.

N. Engl. J. Med.

Ann. Int. Med.

Ann. Int. Med.

Circulation

J. Pharmac. exp. Ther.

Br. J. Pharmac.

Thorax

Research paper
Selective lysosomal uptake and accumulation of the beta-adrenergic antagonist propranolol in cultured and isolated cell systems